The Autologous Gene Editing for Sickle Cell Disease and Transfusion Dependent Beta Thalassemia webinar aired on Thursday, July 18, at 2 p.m. CDT.

This webinar will focus on recent research in the use of hematopoietic cell transplant (HCT) and gene therapy as curative therapies for sickle cell disease (SCD), convening a panel of experts to explore patient eligibility, perceptions, and overcoming barriers to care. Many patients and providers alike are unfamiliar with HCT as a potential curative option for SCD patients, and there are many misperceptions as gene therapy gains more public attention. Demystifying transplant among SCD providers and elucidating inclusion and exclusion criteria for curative therapies can help physicians and families make informed treatment decisions. Encouraging discussion about HCT and gene therapy’s role in the treatment of SCD can help ensure that patients and providers can appropriately weigh their options, increasing access to curative care when appropriate.

This webinar focused on recent research in the use of hematopoietic cell transplant (HCT) for the treatment of sickle cell disease (SCD), convening a panel of experts to discuss ways to improve access for patients with SCD who could benefit from HCT.

This webinar series aired throughout the month of September 2021, in honor of Sickle Cell Awareness Month. This series highlights how to get patients to curative options, treating patients with sickle cell disease, and patients and caregiver experiences throughout the treatment process.

This recorded webinar, held in honor of Sickle Cell Awareness month, delves into crucial topics related to patients with sickle cell disease and transplant. The webinar featured presentations by Genesis Jones, RN, Dr. Mary Eapen from the Medical College of Wisconsin, and Dr. Elizabeth Stenger from UPMC Children’s Hospital of Pittsburgh.

This activity, recorded during Sickle Cell Awareness month, delves into crucial topics related to patients with sickle cell disease and transplant. The webinar features presentations by Rochelle Williams-Belizaire, MPH, CPH, Dr. Santosh Saraf (UIC) and Dr. Mark Walters (UCSF). Additionally, each session includes real patient experiences related to the discussed topics.

This webinar, the inaugural event in the ASTCT & National Marrow Donor Program® (NMDP)/Be The Match® Sickle Cell Webinar Series, was originally broadcast on September 7, 2023, coinciding with Sickle Cell Awareness month. The session featured presentations by clinicians and patient speakers focusing on the referral process for patients with sickle cell disease to curative options with transplant. The topics covered included general principles of referral and consultation, psychosocial supports for patients during the referral process, and successful education models from New Jersey that facilitate connections between community hematology and oncology physicians and transplant specialists.